A prognostic glycolysis-related gene signature in osteosarcoma: implications for metabolic programming, immune microenvironment, and drug response
A risk signature based on GRGs was established for OS, exhibiting robust predictive efficacy for prognostic assessment, and offering significant clinical utility for the prognosis of OS.
Authors
- Jingyi Hou (ORCID: https://orcid.org/0000-0003-0172-3115)
- Huiyao Gu
- Kui Ding (ORCID: https://orcid.org/0000-0002-3196-1539)
- Chawnshang Chang (ORCID: https://orcid.org/0000-0001-8510-3516)
- Naiqiang Zhu (ORCID: https://orcid.org/0000-0002-9540-4408)
- Ning Yang (ORCID: https://orcid.org/0000-0001-5772-3320)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-3702-6541)
- Yanqi Liu (ORCID: https://orcid.org/0000-0003-3499-0201)
- Liguo Zhu
- Xu Wei
- Bin Chen (ORCID: https://orcid.org/0009-0000-9974-9430)
Institutions
- Chengde Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Wangjing Hospital of China Academy of Chinese Medical Sciences (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-04-29
- DOI
- https://doi.org/10.7717/peerj.19369
- Citations
- 4
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.75
Funders
- Natural Science Foundation of Hebei Province